GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Shanghai Pioneer Holding Ltd (HKSE:01345) » Definitions » Days Sales Outstanding

Shanghai Pioneer Holding (HKSE:01345) Days Sales Outstanding : 100.92 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Shanghai Pioneer Holding Days Sales Outstanding?

Shanghai Pioneer Holding's average Accounts Receivable for the six months ended in Dec. 2023 was HK$502 Mil. Shanghai Pioneer Holding's Revenue for the six months ended in Dec. 2023 was HK$908 Mil. Hence, Shanghai Pioneer Holding's Days Sales Outstanding for the six months ended in Dec. 2023 was 100.92.

The historical rank and industry rank for Shanghai Pioneer Holding's Days Sales Outstanding or its related term are showing as below:

HKSE:01345' s Days Sales Outstanding Range Over the Past 10 Years
Min: 66.92   Med: 73.78   Max: 104.03
Current: 104.03

During the past 12 years, Shanghai Pioneer Holding's highest Days Sales Outstanding was 104.03. The lowest was 66.92. And the median was 73.78.

HKSE:01345's Days Sales Outstanding is ranked worse than
87.34% of 640 companies
in the Healthcare Providers & Services industry
Industry Median: 45.94 vs HKSE:01345: 104.03

Shanghai Pioneer Holding's Days Sales Outstanding increased from Dec. 2022 (66.10) to Dec. 2023 (100.92).


Shanghai Pioneer Holding Days Sales Outstanding Historical Data

The historical data trend for Shanghai Pioneer Holding's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pioneer Holding Days Sales Outstanding Chart

Shanghai Pioneer Holding Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 74.50 72.46 66.92 80.84 101.37

Shanghai Pioneer Holding Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 61.97 67.56 66.10 110.35 100.92

Competitive Comparison of Shanghai Pioneer Holding's Days Sales Outstanding

For the Pharmaceutical Retailers subindustry, Shanghai Pioneer Holding's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Pioneer Holding's Days Sales Outstanding Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Shanghai Pioneer Holding's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Shanghai Pioneer Holding's Days Sales Outstanding falls into.



Shanghai Pioneer Holding Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Shanghai Pioneer Holding's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (461.375 + 490.47) / 2 ) / 1713.594*365
=475.9225 / 1713.594*365
=101.37

Shanghai Pioneer Holding's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (513.312 + 490.47) / 2 ) / 907.576*365 / 2
=501.891 / 907.576*365 / 2
=100.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Pioneer Holding  (HKSE:01345) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Shanghai Pioneer Holding Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Shanghai Pioneer Holding's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Pioneer Holding (HKSE:01345) Business Description

Traded in Other Exchanges
N/A
Address
No.15, Lane 88 Wuwei Road, Putuo District, Shanghai, CHN, 200331
Shanghai Pioneer Holding Ltd is an investment holding company. It is engaged in the marketing, promotion, sales, and channel management service for pharmaceutical products and medical devices in China. The company has a portfolio of pharmaceutical products, covering ophthalmology, pain management, cardiovascular, gastroenterology, immunology, gynecology, and other therapeutic areas, and medical devices covering several medical specialties, including ophthalmology, orthopedics, odontology, and wound care. The majority of its revenue derives from the Sales of pharmaceutical products segment. The group operates mainly in PRC.

Shanghai Pioneer Holding (HKSE:01345) Headlines

No Headlines